What is the intrinsic value of BIE.MI?
As of 2025-06-02, the Intrinsic Value of Bioera SpA (BIE.MI) is
15.78 EUR. This BIE.MI valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.04 EUR, the upside of Bioera SpA is
39,948.35%.
Is BIE.MI undervalued or overvalued?
Based on its market price of 0.04 EUR and our intrinsic valuation, Bioera SpA (BIE.MI) is undervalued by 39,948.35%.
15.78 EUR
Intrinsic Value
BIE.MI Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(2.86) - (1.66) |
(2.06) |
-5337.0% |
| DCF (Growth 10y) |
(1.66) - (2.65) |
(2.00) |
-5164.5% |
| DCF (EBITDA 5y) |
(0.90) - (1.12) |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(1.06) - (1.26) |
(1,234.50) |
-123450.0% |
| Fair Value |
15.78 - 15.78 |
15.78 |
39,948.35% |
| P/E |
7.40 - 12.61 |
9.56 |
24169.3% |
| EV/EBITDA |
(1.67) - (1.92) |
(1.78) |
-4606.3% |
| EPV |
(2.34) - (2.44) |
(2.39) |
-6163.3% |
| DDM - Stable |
2.83 - 7.40 |
5.11 |
12882.0% |
| DDM - Multi |
(0.29) - (0.64) |
(0.41) |
-1132.0% |
BIE.MI Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
0.81 |
| Beta |
-0.02 |
| Outstanding shares (mil) |
20.57 |
| Enterprise Value (mil) |
3.79 |
| Market risk premium |
8.31% |
| Cost of Equity |
15.66% |
| Cost of Debt |
7.00% |
| WACC |
7.56% |